Mead Johnson Board Increases Dividend by 13 Percent

  Mead Johnson Board Increases Dividend by 13 Percent

Business Wire

GLENVIEW, Ill. -- February 27, 2013

Mead Johnson Nutrition Company (NYSE: MJN) announced today that its board of
directors has declared a regular quarterly dividend of $0.34 per share for the
quarter ending March 31, 2013, a 13.3 percent increase from the prior rate of
$0.30 per share. The board expects the annualized dividend to be $1.36 per
share.

The dividend will be paid on April 1, 2013, to shareholders of record at close
of business on March 13, 2013.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures,
markets and distributes more than 70 products in over 50 markets worldwide.
The company’s mission is to nourish the world’s children for the best start in
life. The Mead Johnson name has been associated with science-based pediatric
nutrition products for over 100 years. The company’s “Enfa” family of brands,
including Enfamil^® infant formula, is the world’s leading brand franchise in
pediatric nutrition. For more information, visit meadjohnson.com.

Forward-Looking Statements

Certain statements in this news release are forward looking as defined in the
Private Securities Litigation Reform Act of 1995. These statements, which are
identified by words such as “expects,” “intends” and “believes,” involve
certain risks, uncertainties and assumptions that may cause actual results to
differ materially from expectations as of the date of this news release. These
risks include, but are not limited to: (1) the ability to sustain brand
strength, particularly the Enfa family of brands; (2) the effect on the
company's reputation of real or perceived quality issues; (3) the adverse
effect of commodity costs; (4) increased competition from branded, private
label, store and economy-branded products; (5) the effect of an economic
downturn on consumers' purchasing behavior and customers' ability to pay for
product; (6) inventory reductions by customers; (7) the adverse effect of
changes in foreign currency exchange rates; (8) the effect of changes in
economic, political and social conditions in the markets where we operate; (9)
legislative, regulatory or judicial action that may adversely affect the
company's ability to advertise its products or maintain product margins; (10)
the possibility of changes in the Women, Infant and Children (WIC) program, or
participation in WIC; and (11) the ability to develop and market new,
innovative products. For additional information on these and other factors,
see the risk factors identified in the company's periodic reports, including
the annual report on Form 10-K for 2012, quarterly reports on Form 10-Q and
current reports on Form 8-K, filed with, or furnished to, the Securities and
Exchange Commission, available upon request or at meadjohnson.com. The company
undertakes no obligation to publicly update any forward-looking statement,
whether as a result of new information, future events or otherwise.

Contact:

Mead Johnson Nutrition Company
Investors:
Kathy MacDonald, (847) 832-2182
kathy.macdonald@mjn.com
Media:
Christopher Perille, (847) 832-2178
chris.perille@mjn.com
 
Press spacebar to pause and continue. Press esc to stop.